Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Praxis Precision Medicines (PRAX) Equity Ratio (2022 - 2025)

Praxis Precision Medicines (PRAX) has 4 years of Equity Ratio data on record, last reported at 0.94 in Q4 2025.

  • For Q4 2025, Equity Ratio rose 1.54% year-over-year to 0.94; the TTM value through Dec 2025 reached 0.94, up 1.54%, while the annual FY2025 figure was 0.94, 1.54% up from the prior year.
  • Equity Ratio reached 0.94 in Q4 2025 per PRAX's latest filing, up from 0.87 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.95 in Q2 2024 and bottomed at 0.66 in Q1 2023.
  • Average Equity Ratio over 4 years is 0.84, with a median of 0.84 recorded in 2023.
  • Peak YoY movement for Equity Ratio: dropped 17.84% in 2023, then skyrocketed 39.98% in 2024.
  • A 4-year view of Equity Ratio shows it stood at 0.66 in 2022, then increased by 19.83% to 0.79 in 2023, then rose by 16.4% to 0.92 in 2024, then grew by 1.54% to 0.94 in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Ratio were 0.94 in Q4 2025, 0.87 in Q3 2025, and 0.89 in Q2 2025.